{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:30:00Z","timestamp":1768030200121,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41584-024-01159-9","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:02:25Z","timestamp":1725278545000},"page":"599-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is X chromosome inactivation a cause or effect of SLE?"],"prefix":"10.1038","volume":"20","author":[{"given":"R. Hal","family":"Scofield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad, N. et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401, 1878\u20131890 (2023).","journal-title":"Lancet"},{"key":"1159_CR2","doi-asserted-by":"publisher","unstructured":"Roberts, A. L. et al. Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/ard-2024-225585 (2024).","DOI":"10.1136\/ard-2024-225585"},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/acr2.11413","volume":"4","author":"RH Scofield","year":"2022","unstructured":"Scofield, R. H. et al. 47XXY and 47XXX in scleroderma and myositis. ACR Open Rheumatol 4, 528\u2013533 (2022).","journal-title":"ACR Open Rheumatol"},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41431-018-0291-3","volume":"27","author":"E Shvetsova","year":"2019","unstructured":"Shvetsova, E. et al. Skewed X-inactivation is common in the general female population. Eur. J. Hum. Genet. 27, 455\u2013465 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"1159_CR5","doi-asserted-by":"publisher","unstructured":"Syrett, C. M. et al. Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.126751 (2019).","DOI":"10.1172\/jci.insight.126751"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1136\/ard.2010.129999","volume":"69","author":"JC Broen","year":"2010","unstructured":"Broen, J. C. et al. Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis. Ann. Rheum. Dis. 69, 2213\u20132216 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1159_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/sj.ejhg.5201614","volume":"14","author":"T Ozcelik","year":"2006","unstructured":"Ozcelik, T. et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur. J. Hum. Genet. 14, 791\u2013797 (2006).","journal-title":"Eur. J. Hum. Genet."},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1002\/art.24956","volume":"60","author":"E Uz","year":"2009","unstructured":"Uz, E. et al. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum. 60, 3410\u20133412 (2009).","journal-title":"Arthritis Rheum."},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/08916939709003851","volume":"26","author":"Q Huang","year":"1997","unstructured":"Huang, Q. et al. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 26, 85\u201393 (1997).","journal-title":"Autoimmunity"},{"key":"1159_CR10","doi-asserted-by":"publisher","unstructured":"Shaw, T. M. et al. X-linked genes exhibit miR6891-5p-regulated skewing in Sj\u00f6gren\u2019s syndrome. J. Mol. Med. https:\/\/doi.org\/10.1007\/s00109-022-02205-3 (2022).","DOI":"10.1007\/s00109-022-02205-3"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01159-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:11:16Z","timestamp":1727183476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01159-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01159-9","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"2 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.H.S. has received payment from Jensen Pharmaceuticals and Merck Pharmaceuticals for services performed as a member of advisory boards related to Sj\u00f6gren\u2019s disease, and holds grants from the US National Institutes of Health, the US Department of Veterans Affairs and the Sj\u00f6gren\u2019s Foundation. V.M.L. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}